Skip to search formSkip to main contentSkip to account menu

glisolamide

Known as: N-(4-(beta-(5-methylisoxazol-3-carboxamido)-ethyl)benzenesulfonyl)-N(1)-cyclohexylurea, 3-isozazolecarboxamide, N-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-5-methyl-, glysolamide 
A second-generation sulfonylurea with antihyperglycemic activity. Glisolamide is comparable to glyburide and gliquidone in controlling blood glucose… 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Sulfonylurea Compounds

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1984
1984
Effects of biguanides and sulfonylureas on insulin receptors in cultured cells.
The effects of the two groups of oral agents on insulin receptors were studied in several types of cells in tissue culture: MCF-7… 
1984
1984
Pharmacokinetics in man of glysolamide, a low-dose oral antidiabetic drug.
1979
1979
[In vitro effect of glysolamide on blood coagulation].
1979
1979
[Study of the protective activity of glisolamide on experimental atherosclerosis in the rabbit].
1979
1979
[Pharmacokinetic study in the rat of a new hypoglycemic agent: glisolamide].
1978
1978
[Glisolamide, a new sulfanylurea. Pharmacologic characteristics].
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)